Post-ICU Migraine Crisis: My Stay in the Hospital and AfterIf you happened to miss Part 1 of 2 in this series, click here to see what you've missed so far: [Again, as previously noted, I'll do my best to... By Kelly J.May 11, 2021Bookmark for later Reactions 0 reactions Comments0 comments
Several Excedrin® Products Recalled Due to Manufacturing DefectIf you take over-the-counter Excedrin®, you should check your bottle to see if it was affected by a recent manufacturing defect. Several Excedrin products were recalled in late December 2020... By Editorial TeamJanuary 8, 2021Bookmark for later Reactions 0 reactions Comments0 comments
Research Opportunity for Men with Migraine from Aston UniversityNavigating the world of online support groups and forums for men with migraine: What are they gaining from it? My name is Tiago Moutela, I am a Ph.D. researcher at... By Editorial TeamOctober 14, 2020Bookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Updates, July 16: Updates on People at Risk, Testing, Reopening, and a VaccineEven after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are some of the latest developments surrounding COVID-19 for... By Editorial TeamJuly 16, 2020Bookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Updates, June 15: Solidarity Hydroxychloroquine Trials and COVID Vaccine DevelopmentMany of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be challenging. Here are some of the top developments... By Editorial TeamJune 15, 2020Bookmark for later Reactions 0 reactions Comments0 comments
FDA Approves Celecoxib Oral Solution for Acute Treatment Of MigraineOn May 5, 2020, the FDA approved Elyxyb (Celecoxib) for acute treatment of migraine with or without aura in adults. Celecoxib is a non-steroidal anti-inflammatory drug (NSAID). It has similar... By Editorial TeamMay 8, 2020Bookmark for later Reactions 0 reactions Comments3 comments
COVID-19 Updates, May 7: Remdesivir, Antibody Testing, and Reinfection RiskOur world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people... By Editorial TeamMay 5, 2020Bookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Updates, April 7: Face Coverings, Testing, & MedicationsIt is common to feel overwhelmed about COVID-19: so much information changing day-to-day. Here are some of the important COVID-19 stories that may be applicable to people living with one... By Editorial TeamApril 7, 2020Bookmark for later Reactions 0 reactions Comments0 comments
FDA Extends Label of gammaCore for Preventive Treatment of MigraineThe medical technology company, electroCore, has announced the expanded use of their device, gammaCore. The company announced that the United States Food and Drug Administration (US FDA) has granted clearance... By Editorial TeamMarch 31, 2020Bookmark for later Reactions 0 reactions Comments1 comments
Take the Fatigue and Health Survey!The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon.Exhaustion, tiredness, weariness... fatigue. We know chronic... By Editorial TeamMarch 27, 2020Bookmark for later Reactions 0 reactions Comments0 comments
FDA Makes Way for Experimental Drugs to Fight COVID-19On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given... By Editorial TeamMarch 20, 2020Bookmark for later Reactions 0 reactions Comments0 comments
COVID-19: Tips to Reduce Your RiskWith all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to... By Editorial TeamMarch 10, 2020Bookmark for later Reactions 0 reactions Comments0 comments
What to Know About COVID-19For those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can... By Editorial TeamMarch 7, 2020Bookmark for later Reactions 0 reactions Comments0 comments
FDA Approves Nurtec™ (rimegepant): The First Oral Disintegrating CGRP Tablet for MigraineThe US Food and Drug Administration (FDA) has just approved Nurtec™ ODT (oral disintegrating tablet) for the acute treatment of migraine in adults. Nurtec (rimegepant) is the first quick-dissolving oral... By Editorial TeamFebruary 28, 2020Bookmark for later Reactions 0 reactions Comments0 comments
Vyepti™: First Intravenous Migraine Preventive Treatment ApprovedThe United States Food and Drug Administration (US FDA) has just approved Vyepti™ for the preventive treatment of migraine. Vyepti (eptinezumab-jjmr) will be the first intravenous (IV) preventive treatment on... By Editorial TeamFebruary 25, 2020Bookmark for later Reactions 0 reactions Comments14 comments
Excedrin Migraine® And Excedrin Extra Strength® Paused For ProductionGlaxoSmithKline (GSK) has temporarily stopped the production of some of its Excedrin brands. This has created shortages of Excedrin Migraine® and Excedrin Extra Strength® caplets and gel tabs in stores... By Editorial TeamJanuary 22, 2020Bookmark for later Reactions 0 reactions Comments5 comments
Ubrelvy™ (ubrogepant) Approved by FDA for Acute Migraine TreatmentOn December 23, 2019, the U.S. Food and Drug Administration (FDA) approved the use of Ubrelvy™ (ubrogepant) for the acute treatment of migraine, with or without aura. Ubrelvy™ is a... By Editorial TeamDecember 23, 2019Bookmark for later Reactions 0 reactions Comments0 comments
Pediatric Migraine Registry ProgramWhat is pediatric migraine and how many children does it affect? Migraine is common among children, however, it often goes undiagnosed or untreated. About 60% of adolescents complain of headache... By Jaime SandersOctober 16, 2019Bookmark for later Reactions 0 reactions Comments0 comments
FDA Approves New Migraine Treatment Lasmiditan (Reyvow™)The U.S. Food and Drug Administration (FDA) approved a new oral medication for acute treatment of migraine disease this week. In clinical trials, lasmiditan (brand name Reyvow™) was able to... By Editorial TeamOctober 11, 2019Bookmark for later Reactions 0 reactions Comments1 comments
Oral CGRP Shows Promising ResultsMigraine is a complex neurological disorder, and in the U.S., migraine affects 39 million people, including children.1 Effective treatments are important to restore quality of life, address pain and discomfort... By Editorial TeamSeptember 9, 2019Bookmark for later Reactions 0 reactions Comments1 comments
